Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-745-1686
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1978 - 1979
University of ConnecticutResidency, Internal Medicine, 1974 - 1977
Tufts University School of MedicineClass of 1974
Certifications & Licensure
TX State Medical License 1980 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma Start of enrollment: 1993 Jun 01
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study) Start of enrollment: 2003 Feb 01
Publications & Presentations
PubMed
- 86 citationsThe gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomasM. S. Lee, Mark Blick, Sen Pathak, Jennifer M. Trujillo, James J. Butler
Blood. 1987-07-01 - 94 citationsReporting outcomes in Hodgkin's disease and lymphoma.Dennis O. Dixon, Peter McLaughlin, Fredrick B. Hagemeister, Emil J. Freireich, Lillian M. Fuller
Journal of Clinical Oncology. 1987-10-01 - 194 citationsTen-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell ...Jorge E. Romaguera, Luis Fayad, Lei Feng, Kimberly Hartig, Pamela Weaver
British Journal of Haematology. 2010-07-01
Journal Articles
- Long‐Term Overall‐ and Progression‐Free Survival After Pentostatin, Cyclophosphamide and Rituximab Therapy for Indolent Non‐Hodgkin LymphomaPeter McLaughlin, M Alma Rodriguez, Sattva S Neelapu, Anas Younes, Lei Feng, Michelle A Fanale, Felipe Samaniego, Barbara Pro, Luis Fayad, Fredrick Hagemeister, Jorge ..., British Journal of Haematology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
